ReviewClinical epidemiology2014

Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.

Puey Ling Chia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.